RECRUITING

Transpacific TAVR Registry

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This registry evaluates the long-term outcome of Transcatheter aortic valve replacement (TAVR) in real-world clinical practice.

Official Title

a Multinational Multicenter Prospective Transpacific TAVR Registry

Quick Facts

Study Start:2019-06-15
Study Completion:2036-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03826264

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:19 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Not specified
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * All patients undergoing TAVR
  2. * Informed consent
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Duk-woo Park, MD
CONTACT
82230103995
dwpark@amc.seoul.kr
Do-yoon Kang, MD
CONTACT
kdy1218@gmail.com

Principal Investigator

Alan Ching Yuen Yeung, MD
PRINCIPAL_INVESTIGATOR
Stanford University
James D. Flaherty, MD
PRINCIPAL_INVESTIGATOR
Northwestern University

Study Locations (Sites)

Stanford University
Stanford, California, 94305
United States
Northwestern Memorial Hospital
Chicago, Illinois, 60611
United States

Collaborators and Investigators

Sponsor: Duk-Woo Park, MD

  • Alan Ching Yuen Yeung, MD, PRINCIPAL_INVESTIGATOR, Stanford University
  • James D. Flaherty, MD, PRINCIPAL_INVESTIGATOR, Northwestern University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-06-15
Study Completion Date2036-12-31

Study Record Updates

Study Start Date2019-06-15
Study Completion Date2036-12-31

Terms related to this study

Keywords Provided by Researchers

  • TAVR
  • TAVI
  • real-world

Additional Relevant MeSH Terms

  • Heart Valve Diseases
  • Aortic Valve Insufficiency